Compare Regeneron Pharmaceuticals Inc (REGN) vs Advanced Drainage Systems Inc (WMS) Price & Performance

Regeneron Pharmaceuticals (REGN) trades at $746.54, up 0.6% on the day, with a bearish technical signal but strong fundamentals. The stock has consistently beaten earnings estimates in recent quarters, with Q3 2026 results pending. Recent news highlights a significant $8 billion immunology alliance expansion with Sanofi, providing substantial upfront and milestone payments. Cash flow improved in 2025, and profitability remains robust with a net income margin of 27.86%.

The outlook is positive, driven by the expanded Sanofi partnership and promising clinical trial updates, though technical indicators suggest near-term resistance. Risks include competitive pressures in key drug markets and reliance on successful drug development. Analysts are bullish with a consensus price target of $849.84, indicating potential upside from current levels.

Advanced Drainage Systems (WMS) trades at $125.79, down 0.23% on the day, amid a bearish technical signal. The stock exhibits strong fundamentals with a P/E of 21.5 and robust profitability, including a 24.9% ROE. Recent quarterly earnings have consistently beaten estimates, and the company maintains a solid balance sheet with a debt-to-asset ratio of 34.34% as of 2025. A recent dividend declaration and sustainability report highlight ongoing corporate actions.

The outlook for WMS is positive given earnings beats and analyst consensus, but risks include a projected net cash flow decline in 2026 and competitive pressures. The stock presents a growth opportunity with a consensus price target of $188.70, though investors should weigh near-term cash flow trends against long-term fundamentals.